A Pediatric Hem/Onc s Nightmare Weekend on Call: Two Cases of Unusual Bleeding and Bruising

Amy D. Shapiro, MD, is Adjunct Professor of Pediatrics at Michigan State University in East Lansing and Medical Director of the Indiana Hemophilia and Thrombosis Center in Indianapolis. Dr. Shapiro earned a medical degree at New York University School of Medicine in New York City. She went on to complete a pediatric internship and residency as well as a pediatric hematology/oncology fellowship at the University of Colorado Health Sciences Center in Denver. Dr. Shapiro is board certified in pediatrics, with a subspecialty in pediatric hematology/oncology.

A contributor to the medical literature, Dr. Shapiro has numerous textbook chapters and scholarly articles to her credit. She writes on such subjects as prophylaxis in young children with factor VIII deficiency, immunogenetics of hemophilia inhibitors, and von Willebrand disease. Her scholarship appears in journals including Blood, Haemophilia, Journal of Pediatrics, and the British Journal of Haematology.

In addition to her writing endeavors, Dr. Shapiro holds several professional appointments and memberships. She serves on the Medical and Scientific Advisory Council of the National Hemophilia Foundation and is a former chair of the American Thrombosis and Hemostasis Network Board of Directors, for which she continues to be active. Her professional memberships include the World Federation of Hemophilia, the Hemophilia Research Society, and the International Society on Thrombosis and Hemostasis.

Diane J. Nugent, MD, is Clinical Professor of Pediatrics at the University of California School of Medicine in Irvine. Clinical appointments include Medical Director of Children's Hospital of Orange County (CHOC) Hematology and Blood & Donor Services and Chief of the CHOC Children's Specialists Division of Hematology. Dr. Nugent earned a medical degree at the University of California, Los Angeles, School of Medicine. An internship and residency were completed at Denver Affiliated Hospitals in Colorado. She completed fellowship training at Children's Hospital Medical Center and at the Fred Hutchinson Cancer Research Center, both in Seattle, Washington. Dr. Nugent is board certified in pediatrics and pediatric hematology/oncology.

Active in numerous research endeavors, Dr. Nugent is Principal Investigator of the Region IX MCHB Hemophilia Treatment Program. Her clinical and research interests include blood disorders, bone marrow failure, and bleeding and clotting disorders. She is currently involved in more than 40 clinical trials for rare blood disorders.

Dr. Nugent has coauthored more than 100 journal articles and book chapters. Her scholarship has appeared in such journals as Haemophilia, Blood, The New England Journal of Medicine, and Thrombosis Research.

Paula Bolton-Maggs, DM, FRCP, FRCPath, is Consultant Haematologist and Medical Director of the Serious Hazards of Transfusion program (SHOT), a UK-wide haemovigilance scheme based at the Manchester Blood Centre in Plymouth Grove, Manchester. She also has an academic appointment as Honorary Senior Lecturer at the University of Manchester. Dr. Bolton-Maggs trained at Cambridge University, following which she attended Oxford University Clinical Medical School.

 
Regarded as an expert in the field of bleeding disorders, Dr. Bolton-Maggs shares her knowledge through her contributions to the medical literature. She writes on such subjects as rare inherited coagulation disorders, immune thrombocytopenia, laboratory diagnosis of bleeding disorders, and factor XI deficiency. Her work has been published in journals including Blood, Seminars in Hematology, Haemophilia, and the British Journal of Haematology.
 

Since 2004, Dr. Bolton-Maggs has been a member of the Executive Committee of the World Federation of Hemophilia. She is also a member of the American Society of Hematology and the International Society on Thrombosis and Haemostasis.